NEWS

CSL Seqirus is Fully Prepared to Implement the WHO’s Trivalent Influenza Vaccines Strain Selection for the 2025/26 Canadian Influenza Season

CSL Seqirus, a global leader in the protection of public health, confirmed it is fully prepared to deliver its influenza vaccine portfolio for the 2025/26 Canadian influenza season, based on the trivalent strains recommended by the World Health Organization (WHO), which is supported by the National Advisory Committee on Immunization (NACI).1,2